66
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Modulation of Dendritic Cell Function and Cytokine Production to Prevent Thyroid Autoimmunity

, &
Pages 389-396 | Published online: 07 Jul 2009

References

  • Thomas, R., Davis, L.S. and Lipsky, RE. (1994) "Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells", J. Immunol. 152, 2613–2623.
  • Demidem, A., Taylor, J.R., Grammer, S.F. and Streilein, J.W. (1991) "T-lymphocyte-activating properties of epidermal antigen-present-ing cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells", J. Invest. Dennatol. 97, 454–460.
  • Serafini, B., Columba-Cabezas, S., Di Rosa, F. and Aloisi, F. (2000) "Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalo-myelitis", Am. J. Pathol. 157, 1991–2002.
  • Kabel, P.J., Voorbij, RA., van der Gaag, RD., Wiersinga, W.M., de Haan, M. and Drexhage, H.A. (1987) "Dendritic cells in autoimmune thyroid disease", Acta Endocrinol. 281, 42–48.
  • Dahlen, E., Dawe, K., Ohlsson, L. and Hedlund, G. (1998) "Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse", J. Immunol. 160, 3585–3593.
  • Quadbeck, B., Eckstein, AK., Tews, S., Walz, M., Hoermann, R., Mann, K. and Gieseler, R. (2002) "Maturation of thyroidal dendritic cells in Graves' disease", Scand. J. Immunol. 55, 612–620.
  • Dittel, B.N., Visintin, I., Merchant, R.M. and Janeway, C.A., Jr. (1999) "Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalo-myelitis", J. Immunol. 163, 32–39.
  • Caux, C., Ait-Yahia, S., Chemin, K., de Bouteiller, O., Dieu-Nosjean, MC., Homey, B., Massacrier, C., Vanbervliet, B., Zlotnik, A. and Vicari, A. (2000) "Dendritic cell biology and regulation of dendritic cell trafficking by chemokines", Springer Semin. Immunopathol. 22, 345–369.
  • Sozzani, S., Luini, W., Borsatti, A., Polentarutti, N., Thou, D., Piemonti, L., D'Amico, G., Power, CA., Wells, T.N., Gobbi, M., Allavena, P. and Mantovani, A. (1997) "Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines", J. Immunol. 159, 1993–2000.
  • Santiago-Schwarz, F., Anand, R, Liu, S. and Carsons, S.E. (2001) "Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate Th 1 inflammatory-type responses", J. Immunol. 167, 1758–1768.
  • Blanco, R, Palucka, AK., Gill, M., Pascual, V. and Banchereau, J. (2001) "Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus", Science 294, 1540–1543.
  • Adema, G.J., Hartgers, F., Verstraten, R., de Vries, E., Marland, G., Menon, S., Foster, J., Xu, Y, Nooyen, P., McClanahan, T., Bacon, K.B. and Figdor, C.G. (1997) "A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells", Nature 387, 713–717.
  • Banyer, J.L., Hamilton, N.H., Ramshaw, LA. and Ramsay, A.J. (2000) "Cytokines in innate and adaptive immunity", Rev. Immunogenet. 2, 359–373.
  • Romagnani, S. (1996) "Thl and Th2 in human diseases", Clin. Immunol. Immunopathol. 80, 225–235.
  • Romagnani, S. (1997) "The Th 1/Th2 paradigm", Immunol. Today 18, 263–266.
  • Kroemer, G., Hirsch, R, Gonzalez-Garcia, A. and Martinez, C. (1996) "Differential involvement of Th 1 and Th2 cytokines in autoimmune diseases", Autoimmunity 24, 25–33.
  • Liblau, R.S., Singer, S.M. and McDevitt, HO. (1995) "ml and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases", Immunol. Today 16, 34–38.
  • Adorini, L., Guery, J.C. and Trembleau, S. (1996) "Manipulation of the Thl/Th2 cell balance: an approach to treat human autoimmune diseases?", Autoimmunity 23, 53.
  • Weetman, AR (2003) "Autoimmune thyroid disease: propagation and progression", Eur. J. Endocrinol. 148, 1–9.
  • Stassi, G. and De Maria, R. (2002) "Autoimmune thyroid disease: new models of cell death in autoimmunity", Nat. Rev. Immunol. 2, 195–204.
  • Todd, I., Pujol-Borrell, R., Hammond, L.J., Bottazzo, G.F. and Feldmann, M. (1985) "Interferon-gamma induces HLA-DR expression by thyroid epithelium", Clin. Exp. Immunol. 61, 265–273.
  • Stassi, G., Di Liberto, D., Todaro, M., Zeuner, A., Ricci-Vitiani, L., Stoppacciaro, A., Ruco, L., Farina, F., Zummo, G. and De Maria, R. (2000) "Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins", Nat. Immunol. 1, 483–483.
  • Zinkemagel, R.M. (2002) "Anti infection immunity and autoimmun-ity", Ann. NY Acad. Sci. 958, 3–6.
  • Misaki, T., Konishi, J., Nakashima, T., lid.% Y, Kasagi, K., Endo, K., Uchiyama, T., Kuma, K. and Torizuka, K. (1985) "Immuno-histological phenotyping of thyroid infiltrating lymphocytes in Graves' disease and Hashimoto's thyroiditis", Clin. Exp. Immunol. 60, 104–110.
  • Pedersen, BK., Feldt-Rasmussen, U., Bech, K., Perrild, H., Klarlund, K. and Hoier-Madsen, M. (1989) "Characterization of the natural killer cell activity in Hashimoto's and Graves' diseases", Allergy 44, 477–481.
  • Sasian, S., Rojano, J., Gavilan, I., Aguilar, M., Escobar, L. and Giron, J.A. (1998) "Serial analysis of circulating T gamma/delta lymphocyte subpopulations in Graves' disease", Endocr. Res. 24, 285–295.
  • Hidaka, Y., Amino, N., Iwatani, Y., Kaneda, T., Nasu, M., Mitsuda, N., Tanizawa, O. and Miyai, K. (1992) "Increase in peripheral natural killer cell activity in patients with autoimmune thyroid disease", Autoimmunity 11, 239–246.
  • Shard, S., Arreaza, GA., Zucker, P., Mi, Q.S. and Delovitch, T.L. (2002) "Regulation of autoinunune disease by natural kil ler T cells", J. MoL Med. 80, 290–300.
  • Watanabe, H., Inaba, M., Adachi, Y, Sugiura, K., Hisha, H., Iguchi, T., Ito, T., Yasumizu, R., Inaba, K., Yamashita, T. and Ikehara, S. (1999) "Experimental autoimmune thyroiditis induced by thyro-globulin-pulsed dendritic cells", Autoimmunity 31, 273–282.
  • Kabel, P.J., Voorbij, RA., De Haan, M., van der Gaag, RD. and Drexhage, RA. (1988) "Intrathyroidal dendritic cells", J. ClM. EndocrinoL Metab. 66, 199–207.
  • Knight, S.C., Farrant, J., Chan, J., Bryant, A., Bedford, PA. and Bateman, C. (1988) "Induction of autoimmunity with dendritic cells: studies on thyroiditis in mice", Clin. Immunol. Immunopathol. 48, 277–289.
  • Farrant, J., Bryant, A.E., Chan, J. and Himsworth, R.L. (1986) "Thyroglobulin-treated blood dendritic cells induce IgG anti-thyroglobulin antibody in vitro in Hashimoto's thyroiditis", ClM. Immunol. Immunopathol. 41, 433–442.
  • Van Eden, W., Van Der Zee, R., Van Kooten, P., Berlo, SE., Cobelens, P.M., Kavelaars, A., Heijnen, C.J., Prakken, B., Roord, S. and Albani, S. (2002) "Balancing the immune system: Th 1 and Th2", Ann. Rheum. Dis. 61, 25–28.
  • Moser, M. and Murphy, K.M. (2000) "Dendritic cell regulation of TH1-TH2 development", Nat. Immunol. 1, 199–205.
  • Drugarin, D., Negru, S., Koreck, A., Zosin, I. and Cristea, C. (2002) "The pattern of a T(H)1 cytokine in autoimmune thyroiditis", Immunol. Lett. 71, 73–77.
  • Zipris, D., Greiner, D.L., Malkani, S., Whalen, B., Mordes, J.P. and Rossini, A.A. (1996) "Cytokine gene expression in islets and thyroids of BB rats. 1FN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats", J. Immunol. 156, 1315–1321.
  • Braley-Mullen, H., Sharp, G.C., Tang, H., Chen, K., Kyriakos, M. and Bickel, J.T. (1998) "Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis", Am. J. Pathol. 152, 1347–1358.
  • Szelachowska, M., Kretowski, A. and Kinalska, I. (1997) "Increased in vitro interleukin-12 production by peripheral blood in high-risk 1DDM first degree relatives", Honn. Metab. Res. 29, 168–171.
  • Hamilton, F., Black, M., Farquharson, MA., Stewart, C. and Foulis, AK. (1991) "Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma-containing lymphocytes in human thyroid autoimmune disease", Clin. Exp. Immunol. 83, 64–68.
  • Wang, S.H., Bretz, J.D., Phelps, E., Mezosi, E., Arscott, P.L., Utsugi, S. and Baker, J.R., Jr (2002) "A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis", J. Immunol. 168, 2470–2474.
  • Zaccone, P., Hutchings, P., Nicoletti, F., Penna, G., Adorini, L. and Cooke, A. (1999) "The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease", Eur. J. Immunol. 29, 1933–1942.
  • Braley-Mullen, H., Sharp, G.C., Tang, H., Chen, K., Kyriakos, M. and Bickel, J.T. (1998) "Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis", Am. J. Pathol. 152, 1347–1358.
  • Shevach, EM., Chang, J.T. and Segal, B.M. (1999) "The critical role of IL-12 and the IL-12R beta 2 subunit in the generation of pathogenic autoreactive Thl cells", Springer Semin. Immunopathol. 21, 249–262.
  • Zhang, W. and Kong, IC. (1998) "Noninvolvement of IL-4 and IL-10 in tolerance induction to experimental autoimmune thyroiditis", Cell. Immunol. 187, 95–102.
  • Mignon-Godefroy, K., Rott, O., Brazillet, M.P. and Charreire, J. (1995) "Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT). Evidence for IL-10-enhanced cell death in EAT", J. Immunol. 154, 6634–6643.
  • Chen, K., Wei, Y., Sharp, G.C. and Braley-Mullen, H. (2001) "Induction of experimental autoimmune thyroiditis in IL-12-/- mice", J Immunol. 167, 1720–1727.
  • Kaiser, P., Rothwell, L., Vasicek, D. and Hala, K. (2002) "A role for IL-15 in driving the onset of spontaneous autoimmune thyroiditis?", J. Immunol. 168, 4216–4220.
  • Steegmann, J.L., Requena, M.J., Martin-Regueira, P., De La Camara, R., Casado, F., Salvanes, F.R. and Fernandez Ranada, J.M. (2003) "High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alpha", Am. J. HematoL 72, 170–176.
  • Schuppert, F., Rambusch, E., Kirchner, H., Atzpodien, J., Kohn, L.D. and von zur Muhlen, A. (1997) "Patients treated with interferon-alpha, interferon-beta, and interleukin-2 have a different thyroid autoantibody pattern than patients suffering from endogenous autoimmune thyroid disease", Thyroid 7, 837–842.
  • Miraldan, R., Hammond, L.J. and Bottazzo, G.F. (2001) "TH1 and TH2 cytokine control of thyrocyte survival in thyroid autoimmun-ity", Nat. Immunol. 2, 371.
  • Delemarre, F.G., Hoogeveen, PG., De Haan-Meulman, M., Simons, P.J. and Drexhage, H.A. (2001) "Homotypic cluster formation of dendritic cells, a close correlate of their state of maturation. Defects in the biobreeding diabetes-prone rat", J. Leukoc. Biol. 69, 373–380.
  • Weir, CR., Nicolson, K. and Backstrom, B.T. (2002) "Experimental autoimmune encephalomyelitis induction in naive mice by dendritic cells presenting a self-peptide", Immunol. Cell Biol. 80, 14–20.
  • Menges, M., Rossner, S., Voigtlander, C., Schindler, H., Kukutsch, NA., Bogdan, C., Erb, K., Schuler, G. and Lutz, M.B. (2002) "Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoinununity", J. Exp. Med. 195, 15–21.
  • Ardavin, C., Martinez del Hoyo, G., Martin, P., Anjuere, F., Arias, C.F., Mann, AR., Ruiz, S., Parrillas, V. and Hernandez, H. (2001) "Origin and differentiation of dendritic cells", Trends Immunol. 22, 691–700.
  • Vasu, C., Dogan, R.N., Holterman, M.J. and Prabhakar, B.S. (2003) "Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4(+)/CD25(+) T cells and suppresses experimental autoimmune thyroiditis", J. Immunol. 170, 5511 —5522.
  • Dogan, RN., Vasu, C., Holterman, M.J. and Prabhakar, B.S. (2003) "Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease", J. Immunol. 170, 2195–2204.
  • Bour-Jordan, H. and Blueston, J.A. (2002) "CD28 function: a balance of costimulatory and regulatory signals", J. Clin. Immunol. 22, 1–7.
  • Ueda, H., Howson, J.M., Esposito, L., et al. (2003) "Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease", Nature 423, 506–511.
  • Vasu, C., Gorla, SR., Prabhakar, B.S. and Holterman, M.J. (2003) "Targeted engagement of CTLA-4 prevents autoimmune thyroid-itis", Int. Immunol. 15, 641–654.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.